BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2517157)

  • 1. [Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
    Reiterer W
    Z Kardiol; 1989; 78 Suppl 5():63-8. PubMed ID: 2517157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of ischemic heart disease in the elderly. Comparison of diltiazem, verapamil and gallopamil].
    Simonelli P; Papa A; Macciocchi B; Auriemma F; Vetrano A; Scaletta Romeo di Santillo M; Ceriello A
    Minerva Cardioangiol; 1993 May; 41(5):193-204. PubMed ID: 8355859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of stable angina pectoris with gallopamil].
    Pupita G; Mattei O; Mazzara D; Centanni M; Ferretti GF; Rimatori C; Dessì-Fulgheri P; Rappelli A; Russo P
    G Ital Cardiol; 1992 Sep; 22(9):1049-56. PubMed ID: 1291422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
    Hopf R; Fleischer K; Forster A; Mohler C; Schulz PC; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():69-76. PubMed ID: 2698566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter long-term study of gallopamil in patients with coronary heart disease].
    Sućić M; Schiemann J
    Arzneimittelforschung; 1984; 34(11):1587-94. PubMed ID: 6543136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of stress-induced and spontaneous myocardial ischemia in coronary disease patients with slow-release gallopamil--preliminary results of an open study].
    Steinbeck C; Reuschel-Janetschek E; von Arnim T
    Z Kardiol; 1989; 78 Suppl 5():103-7. PubMed ID: 2698561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
    Loskot F; Novotny P; Sucic P; Schneider G
    Z Kardiol; 1989; 78 Suppl 5():89-93. PubMed ID: 2698569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow-release gallopamil evaluated by exercise test and long-term electrocardiography.
    Steinbeck G; Reuschel-Janetschek E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S83-7. PubMed ID: 1284162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Randomized comparison between gallopamil and diltiazem in angiography verified coronary heart disease].
    Zenker GD; Rödl S; Genger K
    Z Kardiol; 1989; 78 Suppl 5():94-7. PubMed ID: 2698570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute and long-term effects of gallopamil (D 600) in stable angina pectoris--a randomized double-blind study].
    Rettig G; Sen S; Schieffer H; Bette L
    Z Kardiol; 1983 Dec; 72(12):746-54. PubMed ID: 6421002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
    Zebe H
    Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
    Hopf R; Drews H; Kaltenbach M
    Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
    Mitrovic V; Oehm E; Minge C; Thürmann P; Schlepper M
    Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year mortality rate in relation to observations at a bicycle exercise test in patients with a suspected or confirmed ischemic event but no or only minor myocardial damage: influence of subsequent revascularization.
    Karlson BW; Sjölin M; Lindqvist J; Caidahl K; Herlitz J
    Am Heart J; 2001 Jun; 141(6):977-84. PubMed ID: 11376313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
    Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
    Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of amlodipine in patients with severe coronary artery disease.
    Navarro Estrada JL; Oliveri R
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S24-8. PubMed ID: 7522284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow-release gallopamil in patients with stable effort angina.
    Cherchi A; Lai C; Onnis E; Solinas R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S75-82. PubMed ID: 1284161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of verapamil in patients with asymptomatic stress-induced ischemia.
    Zilberman A; Rogel S
    Arch Intern Med; 1989 May; 149(5):1062-4. PubMed ID: 2719499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.